Paper abstract: CRISPR-Cas9 gene-editing technology has revolutionised the creation of precise and permanent modifications to DNA, enabling the generation of diverse animal models for investigating potential treatments. Here, we provide a protocol for the use of CRISPR-Cas9 to create murine models of Duchenne Muscular Dystrophy (DMD) along with a step-by-step guide for their phenotypic and molecular characterisation. The experimental procedures include CRISPR microinjection of embryos, molecular testing at the DNA, RNA, and protein levels, forelimb grip strength testing, immunostaining and serum creatine kinase (CK) testing. We further provide suggestions for analysis and interpretation of the generated data, as well as the limitations of our approach. These protocols are designed for researchers who intend on generating and using mouse models to study DMD as well as those seeking a detailed framework of phenotyping to contribute to the broader landscape of genetic disorder investigations.
Protocol summary: We use the forelimb grip strength test to determine the maximum force applied by the mouse onto a grid, as an evaluation of the muscle integrity in the DMD models. The test is based on the tendency of a mouse to instinctively grasp a grid when suspended by the tail, where there is a measure of the maximal peak force generated from the combined front paws (1, 2). The protocol listed here was adapted from the TREAT-NMD standard operating procedure SOP DMD_M.2.2.001 for grip strength testing.